Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients

Fogarty, 2020, COVID19 coagulopathy in Caucasian patients, Br J Haematol, 189, 1044, 10.1111/bjh.16749 Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res, 191, 145, 10.1016/j.thromres.2020.04.013 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, J Am Med Assoc, 323, 1061, 10.1001/jama.2020.1585 Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost, 18, 1094, 10.1111/jth.14817 Al-Samkari, 2020, COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection, Blood, 136, 489, 10.1182/blood.2020006520 Llitjos, 2020, High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients, J Thromb Haemost, 18, 1743, 10.1111/jth.14869 Paranjpe, 2020, Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19, J Am Coll Cardiol, 76, 122, 10.1016/j.jacc.2020.05.001 Jonmarker, 2020, Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients, Crit Care, 24, 653, 10.1186/s13054-020-03375-7 Song, 2020, Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19, Mil Med Res, 7, 19 SETH. Recomendaciones de tromboprofilaxis y tratamiento antitrombótico en pacientes. Soc Española Trombos y Hemost 2020. Thachil, 2020, ISTH interim guidance on recognition and management of coagulopathy in COVID-19, J Thromb Haemost, 18, 1023, 10.1111/jth.14810 Cattaneo, 2020, Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?, Thromb Haemost, 120, 1230, 10.1055/s-0040-1712097 Ackermann, 2020, Pulmonary vascular endothelialitis thrombosis, and angiogenesis in Covid-19, N Engl J Med, 383, 120, 10.1056/NEJMoa2015432 Arnold, 2007, Bleeding during critical illness: a prospective cohort study using a new measurement tool, Clin Investig Med, 30, 93, 10.25011/cim.v30i2.985 Schulman, 2010, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients, J Thromb Haemost, 8, 202, 10.1111/j.1538-7836.2009.03678.x Douma, 2010, Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts, BMJ, 340, 1475c, 10.1136/bmj.c1475 Jiménez, 2021, Incidence of VTE and bleeding among hospitalized patients with COVID-19: a systematic review and meta-analysis, Chest, 159, 1196 Bikdeli, 2021, Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION randomized trial, Thromb Haemost Mattioli, 2020, Safety of intermediate dose of low molecular weight heparin in COVID-19 patients, J Thromb Thrombolysis, 13, 1 Kessler, 2020, Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis, J Thromb Thrombolysis, 50, 5, 10.1007/s11239-020-02244-y Pesavento, 2020, The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience, J Thromb Haemost, 18, 2629, 10.1111/jth.15022